Showing results (991-1000 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|March 24, 2026
Can splenic characteristics predict rectal cancer chemotherapy toxicity and treatment outcomes in rectal cancer patients?Lara Wirth, Alex Besson, Paige Hudson, et al.
Oncology|January 1, 1978
Acetylator phenotype in patients with breast cancerL N Bulovskaya, R G Krupkin, T A Bochina, et al.
Oncology|January 1, 1984
Hepatitis b surface antigen and alphafetoprotein levels in the serum of healthy womenE Kaklamani, Z Zhong-Tang, D Trichopoulos, et al.
Oncology|October 27, 2016
Prognostic Significance of HER-2 and p53 Expression in Gallbladder Carcinoma in North Indian PatientsAnjali Singh, Pramod K Mishra, Sundeep Singh Saluja, et al.
Oncology|June 5, 2023
Response Prediction Model of Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Retrospective StudyMasaki Ueno, Hisashi Kosaka, Hiroya Iida, et al.
Oncology|May 26, 2023
Serotonin Receptors and Acetylcholinesterase Gene Expression Alternations: The Potential Value on Tumor Microenvironment of Gastric CancerFatemeh Abedini, Omolbanin Amjadi, Akbar Hedayatizadeh-Omran, et al.
Oncology|May 28, 2023
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint InhibitorsCho-Han Chiang, Yuan-Jen Chen, Xin Ya See, et al.
Oncology|May 21, 2026
Retrospective comparison of capecitabine plus oxaliplatin and docetaxel plus S-1 as adjuvant chemotherapy for pathological stage III gastric cancerToru Imai, Hidekazu Hirano, Hirokazu Shoji, et al.
Oncology|May 19, 2026
Association between clinicopathological features and BRAF V600E mutation in papillary thyroid carcinoma: a meta-analysis and systematic reviewTao Fu, Jiahao Chen, Xiaxia Jin, et al.
Oncology|May 29, 2026
Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial DiagnosisGakushi Komura, Teiji Kuzuya, Hisanori Muto, et al.
Pageof 526